학술논문

Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial
Document Type
Article
Source
In The Lancet Oncology June 2023 24(6):597-610
Subject
Primary Research
Articles
Language
ISSN
1470-2045